Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector
Download full text from publisher
Other versions of this item:
- Suma Athreye & Dinar Kale & Shyama V. Ramani, 2009. "Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector," Industrial and Corporate Change, Oxford University Press, vol. 18(4), pages 729-759, August.
References listed on IDEAS
- Gehl Sampath, Padmashree, 2006. "Indian Pharma Within Global Reach?," MERIT Working Papers 031, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
CitationsCitations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
- David E. Hojman, 2016. "Getting Innovation Right: The Key to Happiness and Flourishing?," Homo Oeconomicus: Journal of Behavioral and Institutional Economics, Springer, vol. 33(4), pages 311-316, December.
- Havas, Attila, 2010. "Diversity in firms’ innovation strategies and activities: Main findings of interviews and implications in the context of the Hungarian national," MPRA Paper 55852, University Library of Munich, Germany.
- Basant, Rakesh, 2010. "Intellectual Property Protection, Regulation and Innovation in Developing Economies - The Case of Indian Pharmaceutical Industry," IIMA Working Papers WP2010-11-02, Indian Institute of Management Ahmedabad, Research and Publication Department.
- Dinesh Abrol & Pramod Prajapati & Nidhi Singh, 2011. "Globalization of the Indian Pharmaceutical Industry: Implications for Innovation," Institutions and Economies (formerly known as International Journal of Institutions and Economies), Faculty of Economics and Administration, University of Malaya, vol. 3(2), pages 327-365, July.
- Rakesh Basant, 2010. "Intellectual Property Protection, Regulation and Innovation in Developing Economies: The Case of Indian Pharmaceutical Industry," Working Papers id:3208, eSocialSciences.
- Shyama V. Ramani & Samira Guennif, 2012. "Catching up in the Pharmaceutical Sector: Lessons from Case Studies of India and Brazil," Chapters,in: Economic Development as a Learning Process, chapter 5 Edward Elgar Publishing.
- Vivekananda Mukherjee & Shyama Ramani, 2011. "R&D cooperation in emerging industries, asymmetric innovative capabilities and rationale for technology parks," Theory and Decision, Springer, vol. 71(3), pages 373-394, September.
- Hafsi, Taïeb & Hu, Hao, 2016. "Sectoral innovation through competing logics: The case of antidepressants in traditional Chinese medicine," Technological Forecasting and Social Change, Elsevier, vol. 107(C), pages 80-89.
- Bukhvalov, A. & Alekseeva, O., 2016. "International joint venture acquisition by a foreign or local partner," Working Papers 6439, Graduate School of Management, St. Petersburg State University.
- Samira Guennif & Shyama Ramani, 2010.
"Catching up in pharmaceuticals: a comparative study of India and Brazil,"
CEPN Working Papers
- Guennif, Samir & Ramani, Shyama, 2010. "Catching up in pharmaceuticals: a comparative study of India and Brazil," MERIT Working Papers 019, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
- Guennif, Samira & Ramani, Shyama V., 2012. "Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework," Research Policy, Elsevier, vol. 41(2), pages 430-441.
- Mukherjee, Vivekananda & Ramani, Shyama V., 2008. "R&D cooperation, asymmetric technological capabilities and rationale for technology parks," Dresden Discussion Paper Series in Economics 11/08, Technische Universität Dresden, Faculty of Business and Economics, Department of Economics.
- repec:kap:asiapa:v:34:y:2017:i:4:d:10.1007_s10490-017-9527-y is not listed on IDEAS
- Samira Guennif & Shyama Ramani, 2010. "Catching up in pharmaceuticals: a comparative study of India and Brazil," Working Papers hal-00632439, HAL.
More about this item
KeywordsInternational Marketing; R&D Management; India; Pharmaceutical Sector; Corporate Strategy;
- L11 - Industrial Organization - - Market Structure, Firm Strategy, and Market Performance - - - Production, Pricing, and Market Structure; Size Distribution of Firms
- L22 - Industrial Organization - - Firm Objectives, Organization, and Behavior - - - Firm Organization and Market Structure
- L51 - Industrial Organization - - Regulation and Industrial Policy - - - Economics of Regulation
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics
- M31 - Business Administration and Business Economics; Marketing; Accounting; Personnel Economics - - Marketing and Advertising - - - Marketing
- O32 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Management of Technological Innovation and R&D
- O34 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Intellectual Property and Intellectual Capital
- O53 - Economic Development, Innovation, Technological Change, and Growth - - Economywide Country Studies - - - Asia including Middle East
NEP fieldsThis paper has been announced in the following NEP Reports:
- NEP-CSE-2008-06-21 (Economics of Strategic Management)
StatisticsAccess and download statistics
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:unm:unumer:2008041. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Ad Notten). General contact details of provider: http://edirc.repec.org/data/meritnl.html .